These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29202405)

  • 1. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
    Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
    Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
    Banjare L
    Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles.
    Banday AH; Saeed BA; Al-Masoudi NA
    Anticancer Agents Med Chem; 2021; 21(13):1671-1679. PubMed ID: 33238853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
    Lv W; Liu J; Skaar TC; Flockhart DA; Cushman M
    J Med Chem; 2015 Mar; 58(6):2623-48. PubMed ID: 25751283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
    Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
    Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combating breast cancer with non-steroidal aromatase inhibitors (NSAIs): Understanding the chemico-biological interactions through comparative SAR/QSAR study.
    Adhikari N; Amin SA; Saha A; Jha T
    Eur J Med Chem; 2017 Sep; 137():365-438. PubMed ID: 28622580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
    Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
    Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
    Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
    Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of novel synthesized thiazole derivatives as potential aromatase inhibitors against breast cancer.
    Fayad E; Binjawhar DN; Ageeli AA; Alshaya DS; Elsaid FG; Mahmoud AY; Radwan EM; Elian Sophy MA; Mahdy AR
    Future Med Chem; 2024; 16(8):707-721. PubMed ID: 38488019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
    Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
    Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New enantioenriched β-indolyl ketones as aromatase inhibitors: Unraveling heme-ligand interactions by MD simulation and MMPBSA analysis.
    Pasha MH; Gondal HY; Munir S; Alhussain SA; Zaki MEA
    Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400010. PubMed ID: 38578079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
    Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
    Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
    Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.